Other studies using a human prostate cancer cell line (DU-145) or a colorectal cancer cell line (MC-26), treated with 10 and 100 μM NS-398, reported a reduction in the release of pro and active MMP-2 and MMP-9 in the culture media [15,38]. This evidence concerns the gene MMP9 and colorectal cancer.